Gabapentin Presents High Potential for Misuse

Authors

Alberto Coustasse, Marshall UniversityFollow
Stacie Deslich
Susan W. Lanham, Marshall UniversityFollow
Brittany Riley, Marshall UniversityFollow

Document Type

Article

Publication Date

11-2022

Abstract

The FDA Approved Gabapentin in 1993 as a non-controlled substance and it has remained a non-controlled substance at the federal level. The drug was created as an anticonvulsant and used to treat seizure disorders. The medication has also been used to treat hot flashes, neuropathic pain, pain, postoperative nausea, substance abuse issues, and vomiting. It is estimated that approximately 1% of people in the United States misuse gabapentin. This fact has compelled certain states to generate legislative initiatives designed to monitor the use and/or reclassify gabapentin. In 2019, US pharmacies dispensed 69 million prescriptions for gabapentin.

Comments

The copy of record is available from the publisher at https://www.pharmacytimes.com/publications/health-system-edition

Copyright © 2022 Pharmacy Times. Reprinted with permission. All rights reserved.

Recommended Citation

Coustasse, Alberto; Deslich, Stacie; Lanham, Susan W.; Riley, Brittany. Gabapentin Presents High Potential for Misuse. Pharmacy Times Health-System Edition. November 2022, Volume 11, Issue 6 – p 36-37.